Furthermore, activation of STAT1 and STAT3 in the tumor cells strongly correlates with the activation of STAT1 and STAT3 in infiltrating immune cells and infiltration of CD4-, CD8-, and FOXP3-positive immune cells, indicating high immunological tolerance in a subset of HCC patients, as evident by PD-L1 expression. The gene discussed is STAT3; the disease is neoplasm.